The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

Dades bibliogràfiques
Autors principals: Barnett, G, Flashman, E, Kelly, D, Schofield, C, Gershlick, A
Format: Conference item
Publicat: 2013
Descripció
Sumari:

Ítems similars